Gene Therapy

NIH Researchers Develop Personalized Breast Cancer Therapy Approach

February 2, 2022 - National Cancer Institute researchers have revealed an experimental form of immunotherapy that uses a patient’s tumor-fighting immune cells to treat those with metastatic breast cancer, advancing personalized medicine. According to researchers, many individuals with metastatic breast cancer can mount an immune reaction against their tumors, a...

Read More


More Articles

Blood Biomarkers Can Help Determine Post-Pregnancy Depression 

by Erin McNemar, MPA

Michigan-based researchers found that signs of inflammation in blood could predict and identify severe depression during and after pregnancy, promoting precision medicine efforts. By...

Using Biomarkers to Prevent, Cure Neurological Disorders   

by Erin McNemar, MPA

To better understand why so many individuals worldwide suffer from brain diseases, Cleveland Clinic has launched a new study aiming to identify disease biomarkers early, preventing...

Gene Inhibiting Assists Chronic Disease Prevention, Targeted Therapy 

by Erin McNemar, MPA

According to researchers from Massachusetts General Hospital, an olfactory receptor gene that aids in the sense of smell could play a role in the metastasis of breast cancer to the brain. By inhibiting...

Genetic Mutation Data Indicates Ovarian Cancer Risk 

by Erin McNemar, MPA

Cedars Sinai scientists have found the origins of a common ovarian cancer by modeling fallopian tube tissue, allowing physicians to determine how genetic mutations increase an individual’s...

Identifying Genetic Mutations Can Advance Precision Medicine Efforts

by Erin McNemar, MPA

By studying genetic mutations in patients with schizophrenia, researchers can identify disease-associated genetic variants, paving the way for precision medicine. The research was conducted...

Diverse Genome Sequences Lead to Creation of Risk Scores

by Erin McNemar, MPA

By studying diverse populations, researchers found genetic variants associated with blood lipid levels and created a polygenic risk score to predict elevated low-density lipoprotein cholesterol...

How CVS Health Uses NCCN Guidelines to Advance Precision Medicine

by Erin McNemar, MPA

Organizations are constantly looking for ways to enhance treatment and patient experience. By incorporating National Comprehensive Cancer Network (NCCN) guidelines and precision medicine, CVS Health is working to improve cancer patient...

Machine Learning Tool Predicts Kidney Function Response To Treatment

by Erin McNemar, MPA

Using predictive analytics, researchers developed a machine learning tool to determine how lupus nephritis patients will respond to specific treatment options. Inflammatory kidney disease occurs in...

Population Health Disparities In Cancer Care Promotes Precision Medicine

by Erin McNemar, MPA

Mount Sinai researchers have found genetic differences between 14 tumor types in young adults compared to the same cancers in older adults. To address the population health disparities, researchers...

Using Genetic Data For Developing Personalized Cancer Therapies

by Erin McNemar, MPA

Indiana University researchers launched a new study to create personalized therapy for patients with triple-negative breast cancer based on genetic data. According to researchers, risk stratification...

Machine Learning, Predictive Analytics Determine Drug Response

by Erin McNemar, MPA

Cleveland Clinic researchers developed a new machine learning model that uses predictive analytics to determine whether immune checkpoint blockade (ICB), a growing class of immunotherapy drugs, will be...

Genetic Signatures Predict Outcomes, Advance Personalized Treatment

by Erin McNemar, MPA

Baylor College of Medicine researchers have discovered a genetic signature that can predict poor patient outcomes in estrogen-receptor positive (ER+) breast cancer, potentially leading to personalized...

Advancing Personalized Treatment For Throat Cancer Patients

by Erin McNemar, MPA

University of California researchers are studying how to advance personalized treatment for patients with HPV-associated oropharyngeal cancer. The research led by Robert Chin, MD, PhD, a radiation...

Machine Learning Predicts Cancer Treatment Response

by Erin McNemar, MPA

The Georgia Institute of Technology and Ovarian Cancer Institute researchers are using machine learning algorithms to predict how patients will respond to cancer-fighting drugs. Advances in machine...

Genomics Study Reveals Variants Behind Inherited Retinal Dystrophies

by Erin McNemar, MPA

University of California San Diego and Shiley Eye Institute at UC San Diego Health scientists analyzed how inherited retinal dystrophies (IRDs) impact diverse populations of people. Through the...

Using Artificial Intelligence to Diagnose Rare Pediatric Disorders

by Erin McNemar, MPA

According to a collaborative research study from the University of Utah Health, Fabric Genomics, and Rady Children’s Hospital, artificial intelligence-based technology can rapidly diagnose rare...

Improving Precision Medicine Accessibility Among Admixed Populations

by Erin McNemar, MPA

University of California San Diego School of Medicine researchers have been awarded $11.7 million to launch the Genetic & Social Determinants of Health: Center for Admixture Science and Technology...

New Alzheimer’s Treatment Advances Precision Medicine

by Erin McNemar, MPA

In a study by the National Institute on Aging (NIA), researchers have found that a commonly available oral diuretic pill approved by the United States Food and Drug Administration is a potential...

Blood Enzyme Activity Predicts Chronic Disease Progression

by Erin McNemar, MPA

SWOG Cancer Research Network researchers have discovered that blood enzyme activity levels could determine the chronic disease progression of breast cancer.  The study indicated that patients...

Recent Articles